e-Drug3D 1796 |
cas 839712-25-3 |
CLASS NERVOUS SYSTEM |
ROUTE (list) - |
ATC code |
PK parameters Cmax 80 NANOMOLAR |
Target TARGET DOPAMINE D2 RECEPTOR |
DrugCentral D(2) dopamine receptor UNIPROT P14416 DRD2 5-hydroxytryptamine receptor 1A UNIPROT P08908 HTR1A |
Download SDF file | Urea, N-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]- Formula: Calculated chemical properties: MW 399.35 NB_atoms 26 XLogP 3.73 PSA 64.062 NB_HD 3 NB_HA 5 fsp3 0.63 Lipinski(0=no;1=yes) 1 |
FDA - |
Other links: | |
e-Drug3D 1794 |
cas 839712-12-8 |
CLASS NERVOUS SYSTEM |
ROUTE (list) ORAL |
ATC code |
PK parameters Tmax 4.5 HOUR |
Target TARGET DOPAMINE D2 RECEPTOR 5-HT1A RECEPTOR PDB Ligand code = 7RU (link to the list of PDB complexes) Download experimental 3D coordinates of 7RU with added hydrogens |
DrugCentral D(2) dopamine receptor UNIPROT P14416 DRD2 5-hydroxytryptamine receptor 1A UNIPROT P08908 HTR1A |
Download SDF file | Urea, N'-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N-dimethyl- Formula: Calculated chemical properties: MW 427.41 NB_atoms 28 XLogP 4.34 PSA 39.114 NB_HD 1 NB_HA 5 fsp3 0.67 Lipinski(0=no;1=yes) 1 |
FDA NDA 204370 (label) INN (CARIPRAZINE HYDROCHLORIDE) VRAYLAR (ABBVIE) APPROVAL= AP YEAR= 2015 NDA 213932 (pdf not found) INN (CARIPRAZINE HYDROCHLORIDE) CARIPRAZINE HYDROCHLORIDE (SUN PHARM) APPROVAL= AP YEAR= 2022 DISCONTINUED NDA 213984 (pdf not found) INN (CARIPRAZINE HYDROCHLORIDE) CARIPRAZINE HYDROCHLORIDE (ZYDUS) APPROVAL= AP YEAR= 2022 DISCONTINUED NDA 213982 (pdf not found) INN (CARIPRAZINE HYDROCHLORIDE) CARIPRAZINE HYDROCHLORIDE (AUROBINDO PHARMA LTD) APPROVAL= AP YEAR= 2025 DISCONTINUED |
Other links: |